Benzinga | Sep 29, 2020 10:58AM EDT

Why Artelo Biosciences Is Trading Higher Today

Artelo Biosciences (NASDAQ:ARTL) shares are trading higher on Tuesday after the company received Ethics Committee approval in the UK to commence its Phase I/II study of ART27.13.

Artelo Biosciences is a United States-based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system.

Artelo Biosciences shares traded up 27.49% to $1.02 on Tuesday during the time of publication. The stock has a 52-week high of $4.42 and a 52-week low of 61 cents.